Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies

Ähnliche Einträge

• Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
  von: Reina Tonegawa‐Kuji, et al.
  Veröffentlicht: (2025)
• Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
  von: Ronald C. Petersen, et al.
  Veröffentlicht: (2025)
• Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
  von: Linda J. Van Eldik, et al.
  Veröffentlicht: (2024)
• Assessing safety and efficacy in subpopulations in Alzheimer's disease clinical trials: contextualizing representativeness
  von: Guogen Shan, et al.
  Veröffentlicht: (2025)
• Clinically meaningful benefit and real‐world evidence in Alzheimer's disease research and care
  von: Robert Perneczky, et al.
  Veröffentlicht: (2025)